ArticleJournal of multidisciplinary healthcare2025
Unlocking the Diagnostic and Therapeutic Potential of microRNA in Diabetes: A Bibliometric and Visualized Analysis (2003-2023).
Article in Journal of multidisciplinary healthcare, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: MicroRNAs (miRNAs) hold considerable therapeutic potential for diabetes mellitus (DM). Over the past few decades, substantial progress has been made in miRNA-related diabetes research; however, comprehensive bibliometric analyses in this field remain limited. This study aims to comprehensively review the research status of miRNAs in DM, including the contributions of countries, institutions, authors and published journals, and explore the latest progress, research hotspots, and future trends. Methods: Bibliometric analysis was conducted using CiteSpace and VOSviewer by searching relevant literature in the Web of Science Core Collection (WOSCC). With 5197 relevant publications retrieved from January 1, 2003, to October 31, 2023, the field of miRNAs in DM witnessed a generally upward trend in global publications. Results: Global publications on miRNAs in DM showed a sustained upward trajectory. China led in publication output and influence, likely linked to its high DM prevalence. Cluster analysis identified diabetic retinopathy and diabetic nephropathy as primary research foci among co-cited studies. Keyword analysis emphasizes the top 10 words like miRNA, expression, biomarker, insulin resistance, diabetes, diabetes nephropathy, apoptosis, cell, and oxidative stress. Conclusion: Research on miRNAs in DM has grown significantly, with emphasis on understanding pathogenesis and identifying therapeutic targets. This field will be further studied and translated into clinical practice in the future.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.